177 related articles for article (PubMed ID: 22930571)
21. Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice.
Lee W; Ku SK; Na DH; Bae JS
Inflammation; 2015 Oct; 38(5):1911-24. PubMed ID: 25899805
[TBL] [Abstract][Full Text] [Related]
22. Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models.
Lee W; Kim TH; Ku SK; Min KJ; Lee HS; Kwon TK; Bae JS
Toxicol Appl Pharmacol; 2012 Jul; 262(1):91-8. PubMed ID: 22561332
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of polyozellin from Polyozellus multiplex on HMGB1-mediated septic responses.
Yang EJ; Ku SK; Lee W; Song KS; Bae JS
Inflamm Res; 2015 Sep; 64(9):733-46. PubMed ID: 26206236
[TBL] [Abstract][Full Text] [Related]
24. Anti-septic effects of pelargonidin on HMGB1-induced responses in vitro and in vivo.
Min G; Ku SK; Park MS; Park TJ; Lee HS; Bae JS
Arch Pharm Res; 2016 Dec; 39(12):1726-1738. PubMed ID: 27778275
[TBL] [Abstract][Full Text] [Related]
25. Antiseptic Effects of New 3'-N-Substituted Carbazole Derivatives In Vitro and In Vivo.
Lee W; Kwak S; Yun E; Lee JH; Na M; Song GY; Bae JS
Inflammation; 2015 Aug; 38(4):1649-61. PubMed ID: 25743565
[TBL] [Abstract][Full Text] [Related]
26. Orientin inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.
Yoo H; Ku SK; Lee T; Bae JS
Inflammation; 2014 Oct; 37(5):1705-17. PubMed ID: 24771074
[TBL] [Abstract][Full Text] [Related]
27. Anti-septic effects of glyceollins in HMGB1-induced inflammatory responses in vitro and in vivo.
Lee W; Ku SK; Lee YM; Bae JS
Food Chem Toxicol; 2014 Jan; 63():1-8. PubMed ID: 24184598
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory activities of oleanolic acid on HMGB1 activated HUVECs.
Yang EJ; Lee W; Ku SK; Song KS; Bae JS
Food Chem Toxicol; 2012 May; 50(5):1288-94. PubMed ID: 22386814
[TBL] [Abstract][Full Text] [Related]
29. Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
Zhang Z; Zhang L; Zhou C; Wu H
Int Immunopharmacol; 2014 Nov; 23(1):14-26. PubMed ID: 25133650
[TBL] [Abstract][Full Text] [Related]
30. Barrier protective functions of hederacolchiside-E against HMGB1-mediated septic responses.
Lee W; Choi HJ; Sim H; Choo S; Song GY; Bae JS
Pharmacol Res; 2021 Jan; 163():105318. PubMed ID: 33246171
[TBL] [Abstract][Full Text] [Related]
31. Biapenem reduces sepsis mortality via barrier protective pathways against HMGB1-mediated septic responses.
Kim J; Choo S; Sim H; Baek MC; Bae JS
Pharmacol Rep; 2021 Jun; 73(3):786-795. PubMed ID: 33515401
[TBL] [Abstract][Full Text] [Related]
32. Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice.
Lee W; Ku SK; Bae JS
Toxicol Appl Pharmacol; 2017 Aug; 329():202-211. PubMed ID: 28610995
[TBL] [Abstract][Full Text] [Related]
33. Anti-Septic Functions of Cornuside against HMGB1-Mediated Severe Inflammatory Responses.
Kim N; Kim C; Ryu SH; Lee W; Bae JS
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216180
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
Lee W; Ku SK; Bae JW; Bae JS
Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo.
Yoo H; Ku SK; Baek YD; Bae JS
Inflamm Res; 2014 Mar; 63(3):197-206. PubMed ID: 24292859
[TBL] [Abstract][Full Text] [Related]
36. Exendin-4 inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.
Lee W; Ku SK; Park EJ; Na DH; Kim KM; Bae JS
Inflammation; 2014 Oct; 37(5):1876-88. PubMed ID: 24826914
[TBL] [Abstract][Full Text] [Related]
37. Role of moesin in HMGB1-stimulated severe inflammatory responses.
Lee W; Kwon OK; Han MS; Lee YM; Kim SW; Kim KM; Lee T; Lee S; Bae JS
Thromb Haemost; 2015 Aug; 114(2):350-63. PubMed ID: 25947626
[TBL] [Abstract][Full Text] [Related]
38. Vascular barrier protective effects of piperlonguminine in vitro and in vivo.
Ku SK; Kim JA; Bae JS
Inflamm Res; 2014 May; 63(5):369-79. PubMed ID: 24468889
[TBL] [Abstract][Full Text] [Related]
39. Ketamine attenuates high mobility group box-1-induced inflammatory responses in endothelial cells.
Liu Z; Wang Z; Han G; Huang L; Jiang J; Li S
J Surg Res; 2016 Feb; 200(2):593-603. PubMed ID: 26453003
[TBL] [Abstract][Full Text] [Related]
40. Reduning injection and its effective constituent luteoloside protect against sepsis partly via inhibition of HMGB1/TLR4/NF-κB/MAPKs signaling pathways.
Wang Z; Chen W; Li Y; Zhang S; Lou H; Lu X; Fan X
J Ethnopharmacol; 2021 Apr; 270():113783. PubMed ID: 33421596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
